Zhanwang Wang

680 total citations
21 papers, 381 citations indexed

About

Zhanwang Wang is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Zhanwang Wang has authored 21 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 10 papers in Molecular Biology and 9 papers in Cancer Research. Recurrent topics in Zhanwang Wang's work include Ferroptosis and cancer prognosis (12 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (5 papers). Zhanwang Wang is often cited by papers focused on Ferroptosis and cancer prognosis (12 papers), Cancer-related molecular mechanisms research (8 papers) and RNA modifications and cancer (5 papers). Zhanwang Wang collaborates with scholars based in China and United States. Zhanwang Wang's co-authors include Ke Cao, Dong He, Yuxing Zhu, Xingyu Chen, Mengqing Xiao, Yi Jin, Yaxin Cheng, Haotian Chen, Lian Gong and Lian Gong and has published in prestigious journals such as Oncogene, Nanoscale and Frontiers in Immunology.

In The Last Decade

Zhanwang Wang

21 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhanwang Wang China 12 247 158 137 97 74 21 381
Baoan Hong China 11 292 1.2× 265 1.7× 132 1.0× 77 0.8× 47 0.6× 33 455
Maoyu Wang China 10 257 1.0× 174 1.1× 110 0.8× 49 0.5× 46 0.6× 31 383
Ellen C. de Heer Netherlands 7 168 0.7× 139 0.9× 70 0.5× 111 1.1× 36 0.5× 8 345
Dorothee Franziska Strohmer China 5 174 0.7× 110 0.7× 100 0.7× 98 1.0× 22 0.3× 6 309
Bingqiu Xiu China 9 282 1.1× 264 1.7× 64 0.5× 94 1.0× 122 1.6× 38 501
Ezequiel J. Tolosa United States 11 221 0.9× 84 0.5× 112 0.8× 135 1.4× 31 0.4× 24 356
Yaping Guan China 11 241 1.0× 129 0.8× 77 0.6× 156 1.6× 39 0.5× 25 431
Ju Guo China 13 286 1.2× 190 1.2× 161 1.2× 74 0.8× 67 0.9× 41 458
Liangliang Yang China 8 245 1.0× 208 1.3× 89 0.6× 133 1.4× 29 0.4× 10 436

Countries citing papers authored by Zhanwang Wang

Since Specialization
Citations

This map shows the geographic impact of Zhanwang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanwang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanwang Wang more than expected).

Fields of papers citing papers by Zhanwang Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhanwang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanwang Wang. The network helps show where Zhanwang Wang may publish in the future.

Co-authorship network of co-authors of Zhanwang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhanwang Wang. A scholar is included among the top collaborators of Zhanwang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhanwang Wang. Zhanwang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhanwang, Yi Jin, Dong He, et al.. (2025). Targeting ALG3/FOXD1/BNIP3 Axis Prevents Mitophagy and Gemcitabine Resistance of Nasopharyngeal Carcinoma. International Journal of Biological Sciences. 21(5). 1894–1913. 1 indexed citations
2.
3.
Cheng, Yaxin, Yuxing Zhu, Mengqing Xiao, et al.. (2023). circRNA_0067717 promotes paclitaxel resistance in nasopharyngeal carcinoma by acting as a scaffold for TRIM41 and p53. Cellular Oncology. 46(3). 677–695. 17 indexed citations
4.
Gong, Lian, Ming Zhong, Kai Gong, et al.. (2023). Multi-Omics Analysis and Verification of the Oncogenic Value of CCT8 in Pan-Cancers. Journal of Inflammation Research. Volume 16. 2297–2315. 6 indexed citations
5.
Chen, Haotian, Yao Zhang, Xingyu Chen, et al.. (2023). Hypoxia is correlated with the tumor immune microenvironment: Potential application of immunotherapy in bladder cancer. Cancer Medicine. 12(24). 22333–22353. 2 indexed citations
6.
Jin, Yi, et al.. (2022). Comprehensive development and validation of gene signature for predicting survival in patients with glioblastoma. Frontiers in Genetics. 13. 900911–900911. 10 indexed citations
7.
Jin, Yi, et al.. (2022). An Integrated Analysis of Prognostic Signature and Immune Microenvironment in Tongue Squamous Cell Carcinoma. Frontiers in Oncology. 12. 891716–891716. 7 indexed citations
8.
Jin, Yi, Zhanwang Wang, Dong He, et al.. (2021). Identification of novel subtypes based on ssGSEA in immune‐related prognostic signature for tongue squamous cell carcinoma. Cancer Medicine. 10(23). 8693–8707. 61 indexed citations
9.
Jin, Yi, Zhanwang Wang, Dong He, et al.. (2021). Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma. Frontiers in Immunology. 12. 637933–637933. 55 indexed citations
10.
Chen, Xingyu, Haotian Chen, Dong He, et al.. (2021). Analysis of Tumor Microenvironment Characteristics in Bladder Cancer: Implications for Immune Checkpoint Inhibitor Therapy. Frontiers in Immunology. 12. 672158–672158. 26 indexed citations
11.
Gong, Lian, Mengqing Xiao, Dong He, et al.. (2021). LINC00467 Promotes Tumor Progression via Regulation of the NF-kb Signal Axis in Bladder Cancer. Frontiers in Oncology. 11. 652206–652206. 14 indexed citations
12.
Zhang, Yeyu, Yuxing Zhu, Mengqing Xiao, et al.. (2021). The Long Non-coding RNA TMPO-AS1 Promotes Bladder Cancer Growth and Progression via OTUB1-Induced E2F1 Deubiquitination. Frontiers in Oncology. 11. 643163–643163. 15 indexed citations
13.
Chen, Xingyu, Dong He, Yao Zhang, et al.. (2021). CD8+ T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer. Oncogene. 40(43). 6223–6234. 67 indexed citations
14.
Chen, Xingyu, Dong He, Zhanwang Wang, et al.. (2021). Analysis of Autophagy-Related Signatures Identified Two Distinct Subtypes for Evaluating the Tumor Immune Microenvironment and Predicting Prognosis in Ovarian Cancer. Frontiers in Oncology. 11. 616133–616133. 16 indexed citations
15.
Jin, Yi, Zhanwang Wang, Dong He, et al.. (2021). Analysis of Ferroptosis-Mediated Modification Patterns and Tumor Immune Microenvironment Characterization in Uveal Melanoma. Frontiers in Cell and Developmental Biology. 9. 685120–685120. 20 indexed citations
16.
Hu, Xueying, Liang Xiang, Dong He, et al.. (2021). The long noncoding RNA KTN1-AS1 promotes bladder cancer tumorigenesis via KTN1 cis-activation and the consequent initiation of Rho GTPase-mediated signaling. Clinical Science. 135(3). 555–574. 18 indexed citations
17.
Deng, Liping, Hongliang Zeng, Xueying Hu, et al.. (2021). Se@Albumin nanoparticles ameliorate intestinal mucositis caused by cisplatinviagut microbiota-targeted regulation. Nanoscale. 13(25). 11250–11261. 18 indexed citations
18.
Chen, Xingyu, Yi Jin, Lian Gong, et al.. (2020). Bioinformatics Analysis Finds Immune Gene Markers Related to the Prognosis of Bladder Cancer. Frontiers in Genetics. 11. 607–607. 21 indexed citations
19.
Chen, Hui, et al.. (1996). Copolymerization of Ethylene/Hexene-1 with TiCl4/SiO2-MgCl2 Supported Catalyst. Chinese Journal of Applied Chemistry. 13(5). 76–78. 1 indexed citations
20.
Zhang, Xuequan, et al.. (1994). DSC and 13C NMR studies of ethylene‐propene copolymers prepared by a highly active and stereospecific catalyst. Macromolecular Chemistry and Physics. 195(3). 1063–1073. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Baoan Hong Breakdown of academic impact, for papers by Maoyu Wang Breakdown of academic impact, for papers by Ellen C. de Heer Breakdown of academic impact, for papers by Dorothee Franziska Strohmer Breakdown of academic impact, for papers by Bingqiu Xiu Breakdown of academic impact, for papers by Ezequiel J. Tolosa Breakdown of academic impact, for papers by Yaping Guan Breakdown of academic impact, for papers by Ju Guo Breakdown of academic impact, for papers by Liangliang Yang
Rankless by CCL
2026